Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above
PHASE3
The present study is designed to confirm the safety and immunogenicity of t...
Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above
PHASE3
This protocol was designed to evaluate the safety, clinical tolerability an...
Status
Completed
Location
University of Rostock, Department Tropical Medicine and Infectious Diseases